^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             35    10631001 10631002 10631003    
                           11601006 11601007 13031001    
                           13031004 13581001 13581014    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731006 19831001 19831005    
                           19831008 19901003             
      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         35
              Max Obs per Subject               2


                    Number of Observations

          Number of Observations Read              59
          Number of Observations Used              59
          Number of Observations Not Used           0


 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       410.14735845                
          1              2       402.03636520      0.00036892
          2              1       401.97388407      0.00000774
          3              1       401.97265941      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           147.02
                UN(2,1)     id          81.0504
                UN(2,2)     id           117.93
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             -2 Res Log Likelihood           402.0
             AIC (Smaller is Better)         408.0
             AICC (Smaller is Better)        408.5
             BIC (Smaller is Better)         412.6


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          8.17          0.0168


 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1    29.4      13.00    0.0011
      trtn                  2    27.1       0.08    0.9244
      AVISITN               1    21.2       2.22    0.1511
      AVISITN*trtn          2    20.9       0.18    0.8367
      BASE*AVISITN          1    21.5       0.96    0.3378
      SSNRISN               1    27.5       0.01    0.9402
      AVISITN*SSNRISN       1    20.8       1.46    0.2400


 
 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            4   1      -17.1055     4.3261   28.4
 AVISITN*trtn            4   2      -14.3538     3.8373     29
 AVISITN*trtn            4   3      -16.3410     4.0157   28.4
 AVISITN*trtn           12   1      -21.7713     4.4599     23
 AVISITN*trtn           12   2      -20.8873     3.8226   22.6
 AVISITN*trtn           12   3      -19.9905     4.1387     23

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            4   1        -3.95     0.0005     0.05
 AVISITN*trtn            4   2        -3.74     0.0008     0.05
 AVISITN*trtn            4   3        -4.07     0.0003     0.05
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn           12   1        -4.88     <.0001     0.05
 AVISITN*trtn           12   2        -5.46     <.0001     0.05
 AVISITN*trtn           12   3        -4.83     <.0001     0.05

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            4   1      -25.9614     -8.2496
    AVISITN*trtn            4   2      -22.2022     -6.5053
    AVISITN*trtn            4   3      -24.5610     -8.1210
    AVISITN*trtn           12   1      -30.9974    -12.5451
    AVISITN*trtn           12   2      -28.8019    -12.9728
    AVISITN*trtn           12   3      -28.5522    -11.4287
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              4  2       -2.7517
  AVISITN*trtn           4  1              4  3       -0.7644
  AVISITN*trtn           4  1             12  1        4.6658
  AVISITN*trtn           4  1             12  2        3.7818
  AVISITN*trtn           4  1             12  3        2.8850
  AVISITN*trtn           4  2              4  3        1.9873
  AVISITN*trtn           4  2             12  1        7.4175
  AVISITN*trtn           4  2             12  2        6.5336
  AVISITN*trtn           4  2             12  3        5.6367
  AVISITN*trtn           4  3             12  1        5.4302
  AVISITN*trtn           4  3             12  2        4.5463
  AVISITN*trtn           4  3             12  3        3.6494
  AVISITN*trtn          12  1             12  2       -0.8839
  AVISITN*trtn          12  1             12  3       -1.7808
  AVISITN*trtn          12  2             12  3       -0.8969
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              4  2        5.2530
  AVISITN*trtn           4  1              4  3        5.4512
  AVISITN*trtn           4  1             12  1        4.2405
  AVISITN*trtn           4  1             12  2        5.4797
  AVISITN*trtn           4  1             12  3        5.7487
  AVISITN*trtn           4  2              4  3        4.9009
  AVISITN*trtn           4  2             12  1        5.5937
  AVISITN*trtn           4  2             12  2        3.7240
  AVISITN*trtn           4  2             12  3        5.2721
  AVISITN*trtn           4  3             12  1        5.7633
  AVISITN*trtn           4  3             12  2        5.1758
  AVISITN*trtn           4  3             12  3        3.9426
  AVISITN*trtn          12  1             12  2        5.2750
  AVISITN*trtn          12  1             12  3        5.4455
  AVISITN*trtn          12  2             12  3        4.9993
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              4  2      28.8    -0.52
AVISITN*trtn           4  1              4  3      28.4    -0.14
AVISITN*trtn           4  1             12  1      20.5     1.10
AVISITN*trtn           4  1             12  2        45     0.69
AVISITN*trtn           4  1             12  3      44.5     0.50
AVISITN*trtn           4  2              4  3      28.9     0.41
AVISITN*trtn           4  2             12  1        43     1.33
AVISITN*trtn           4  2             12  2      21.2     1.75
AVISITN*trtn           4  2             12  3      45.1     1.07
AVISITN*trtn           4  3             12  1        43     0.94
AVISITN*trtn           4  3             12  2      45.8     0.88
AVISITN*trtn           4  3             12  3      20.6     0.93
AVISITN*trtn          12  1             12  2      22.7    -0.17
AVISITN*trtn          12  1             12  3      22.5    -0.33
AVISITN*trtn          12  2             12  3        23    -0.18
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              4  2        0.6044
  AVISITN*trtn           4  1              4  3        0.8895
  AVISITN*trtn           4  1             12  1        0.2840
  AVISITN*trtn           4  1             12  2        0.4936
  AVISITN*trtn           4  1             12  3        0.6182
  AVISITN*trtn           4  2              4  3        0.6881
  AVISITN*trtn           4  2             12  1        0.1918
  AVISITN*trtn           4  2             12  2        0.0938
  AVISITN*trtn           4  2             12  3        0.2907
  AVISITN*trtn           4  3             12  1        0.3514
  AVISITN*trtn           4  3             12  2        0.3843
  AVISITN*trtn           4  3             12  3        0.3654
  AVISITN*trtn          12  1             12  2        0.8684
  AVISITN*trtn          12  1             12  3        0.7467
  AVISITN*trtn          12  2             12  3        0.8592
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
   AVISITN*trtn           4  1             12  1        0.05
   AVISITN*trtn           4  1             12  2        0.05
   AVISITN*trtn           4  1             12  3        0.05
   AVISITN*trtn           4  2              4  3        0.05
   AVISITN*trtn           4  2             12  1        0.05
   AVISITN*trtn           4  2             12  2        0.05
   AVISITN*trtn           4  2             12  3        0.05
   AVISITN*trtn           4  3             12  1        0.05
   AVISITN*trtn           4  3             12  2        0.05
   AVISITN*trtn           4  3             12  3        0.05
   AVISITN*trtn          12  1             12  2        0.05
   AVISITN*trtn          12  1             12  3        0.05
   AVISITN*trtn          12  2             12  3        0.05
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              4  2      -13.4990
  AVISITN*trtn           4  1              4  3      -11.9234
  AVISITN*trtn           4  1             12  1       -4.1667
  AVISITN*trtn           4  1             12  2       -7.2549
  AVISITN*trtn           4  1             12  3       -8.6968
  AVISITN*trtn           4  2              4  3       -8.0371
  AVISITN*trtn           4  2             12  1       -3.8631
  AVISITN*trtn           4  2             12  2       -1.2068
  AVISITN*trtn           4  2             12  3       -4.9813
  AVISITN*trtn           4  3             12  1       -6.1927
  AVISITN*trtn           4  3             12  2       -5.8729
  AVISITN*trtn           4  3             12  3       -4.5597
  AVISITN*trtn          12  1             12  2      -11.8041
  AVISITN*trtn          12  1             12  3      -13.0598
  AVISITN*trtn          12  2             12  3      -11.2394
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              4  2        7.9955
  AVISITN*trtn           4  1              4  3       10.3945
  AVISITN*trtn           4  1             12  1       13.4983
  AVISITN*trtn           4  1             12  2       14.8186
  AVISITN*trtn           4  1             12  3       14.4668
  AVISITN*trtn           4  2              4  3       12.0116
  AVISITN*trtn           4  2             12  1       18.6981
  AVISITN*trtn           4  2             12  2       14.2740
  AVISITN*trtn           4  2             12  3       16.2547
  AVISITN*trtn           4  3             12  1       17.0531
  AVISITN*trtn           4  3             12  2       14.9655
  AVISITN*trtn           4  3             12  3       11.8585
  AVISITN*trtn          12  1             12  2       10.0363
  AVISITN*trtn          12  1             12  3        9.4982
  AVISITN*trtn          12  2             12  3        9.4457
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: The LS means, SEs,LS Mean Diff, 95% (CI) and p-value 
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
